CYP19A1 and neoplasm: This therapeutic inflammation can both promote tumor growth and metastasis, as well as enhance the presentation of tumor antigens, leading to an antitumor immune response.[35] Endocrine therapies such as tamoxifen or aromatase inhibitors may regulate immune function and inflammatory pathways, but their direct impact on autoimmunity remains unclear.